BHI Weekly Newsletter Archives Archives - Page 37 of 66

May 08 2018

Love0

303rd Edition – May 8, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

May 8, 2018

Montgomery County, Maryland-based BeneVir Biopharm, Inc. to be acquired by Janssen Biotech, Inc. for up to $1.04B

Company’s announcement latest in recent trend of significant investment in Montgomery County biohealth companies.

BeneVir Biopharm, Inc. (BeneVir), a privately-held Montgomery County biotech company, has entered into an agreement under which it will be acquired by Janssen Biotech, Inc., a Johnson & Johnson company for up to $1.04 billion. Under the terms of the agreement, Janssen will make an upfront cash payment of $140 million at closing of the transaction, plus additional contingent payments of up to $900 million based on achievement of certain predetermined milestones. BeneVir was a client of BioHealth Innovation (BHI) from 2013 until its Series A investment in 2014.

2018 BioHealth Capital Region Forum Survey…Please complete

As we wrap up this year’s Forum and begin planning for 2019, we would like to hear from you! Tell us what you loved, what we can improve, and what you are most interested in seeing from the BioHealth Capital Region in the coming year.

Click here to complete the 2018 BHCR Forum Attendee Survey. We thank you in advance for your time in providing your feedback.

Save the Date for 2019! The 2019 BioHealth Capital Region Forum will take place on April 8-9, 2019.

These Are the 25 Public Colleges With the Biggest Payback – University of Maryland College Park Made the List

How much is an undergraduate degree really worth? The average 20-year payoff for a bachelor’s degree—even after factoring in tuition and other college costs—is roughly $225,000, according to salary data released Tuesday from PayScale.

HC2 Announces Pansend Life Sciences Portfolio Company BeneVir Biopharm to be Acquired by Janssen Biotech, Inc. for up to $1.04 Billion NYSE:HCHC

HC2 Holdings, Inc. (“HC2”) (NYSE:HCHC), a diversified holding company, announced today that BeneVir Biopharm, Inc. (“BeneVir”), a privately-held biotechnology company developing oncolytic immunotherapies for the treatment of cancer, has entered into a definitive agreement to be acquired by Janssen Biotech, Inc. (“Janssen”).

Mechanistic and Human Translational Results for BT-11 in Models of IBD – Landos Biopharma

Landos Biopharma, Inc., an emerging biopharmaceutical company focused on developing improved treatments for autoimmune diseases, announced the publication of findings on the mechanisms of action for its top lead candidate, BT-11, in Inflammatory Bowel Diseases, the Official Journal of the Crohn’s & Colitis Foundation. The study concludes that through the activation of the Lanthionine Synthetase C-Like 2 (LANCL2) pathway, BT-11 induces changes in the interface of inflammation and metabolism within immune cells in the gut that are critical to provide lasting therapeutic efficacy against inflammatory bowel disease (IBD). These changes in metabolism enhance regulatory CD4+ T helper cell responses and promote lasting therapeutic actions locally within the gut. The mechanistic findings demonstrate the translatability of the therapeutic efficacy of BT-11 to the clinic.

Horsham-based Janssen Biotech, a Johnson & Johnson subsidiary, to buy Benvir BioPharm – Baltimore Business Journal

Janssen Biotech has entered into a definitive agreement to acquire a privately-held biopharmaceutical company focused on the red-hot field of cancer immunology.

Financial terms of the deal for BeneVir BioPharm are being kept confidential.

MoCo Supports Businesses

MCEDC SUPPORTS BUSINESS

FY 18 HIGHLIGHTS

Highmark Health’s VITAL Innovation Program to evaluate WellDoc’s® BlueStar® mobile app for

Highmark Health announced today that through its VITAL Innovation Program, a test-and-learn platform, it will be evaluating WellDoc’s® BlueStar® mobile app, an FDA-cleared, proven digital therapeutic for individuals with type 2 diabetes.

Can the U.S. Get 1 Million People to Volunteer Their Genomes? – Scientific American

One of the enduring mysteries of medicine is how individual genes, environment and lifestyle may combine to spark sickness or protect us from it. Unraveling this puzzle remains essential for scientists hoping to achieve the elusive goal of offering tailored treatments or personalized prevention plans.

FDA Unveils Health Data Science Projects Under Incubator Program

Scott Gottlieb, commissioner of the Food and Drug Administration, has introduced information technology initiatives under the agency’s data science incubator program during the Health Datapalooza conference in Washington, D.C., MedCityNews reported Thursday.

WHO WILL LEAD BALTIMORE’S TECHNOLOGY COMPANIES? A DISCUSSION ABOUT TALENT DEVELOPMENT – attracting it, acquiring it, managing and developing it

When: Thursday, May 17, 20184:00 – 7:00 PM EST Where: University of Maryland BioPark, 801 West Baltimore Street, Baltimore, MD 21201

Join the fourth in the TEDCO funded Anchor Ventures events series for an important discussion about Talent. Our expert panel will discuss how to draw the right candidates to your company, the role personnel plays in the investment process, opportunities for enhancing your existing team, and the regional supply of entrepreneurial talent.

BioBuzz with UMBC Shady Grove

When: Wednesday, May 16, 2018 from 5:00 PM to 7:00 PM EDT

Where: UMBC Shady Grove, 9630 Gudelsky Drive ,Rockville, MD 20850

Join BioBuzz and sponsor UMBC Shady Grove in Rockville on May 16th for our next great networking event. UMBC at The Universities at Shady Grove (USG) has a 17+ year history of providing high caliber and industry desired academic programs in Rockville, MD. This Fall, UMBC is launching its first Bachelors of Science degree at USG in Translational Life Science Technology. This degree, designed in partnership with Montgomery College, combines the theory of a traditional life science degree with real-world applications used by scientists in academic and industry research.

VA BEACH BIO INNOVATION CHALLENGE Letter of Intent Form

This is the Letter of Intent Form (LOI) for Phase 0 of the VA BEACH BIO INNOVATION Startup Challenge. The Team Leader of each team should fill out and submit one form for this challenge. The last date to submit an LOI is May 31st.

Page 1: Basic information and Confidentiality Page 2: Additional Team information (can be completed during Phase 1)

Anyone can Enter!

No minimum team size – you can enter individually Your Background: Anyone with an entrepreneurial spirit! No Geography Restrictions: This challenge welcomes international participants

Inova 2018 Discovery Series: Early Stage Investing in Health Technology

Come join us on June 21, 2018 for our first event of the INOVA 2018 Discovery Series.

Inova Center for Personalized Health Conference Center – 3225 Gallows Road, Fairfax, VA 22031

6:00pm – Reception

7:00pm – Presentation: State of Healthcare Investing; Analysis: Investor Panel Discussion/Q&A

1.13M Patient Records Breached from January to March 2018 – Protenus

1,129,744 patient records were breached between January and March 2018, according to new data released today in the Protenus Breach Barometer. Published by Protenus, an artificial intelligence platform used by top health systems to analyze every access to patient data inside the electronic health record (EHR), the Breach Barometer is the industry’s definitive source for health data breach reporting.

Baltimore tech company leaders appointed to TEDCO board – Technical.ly Baltimore

A pair of Baltimore-based tech leaders are joining the board of directors for TEDCO.

With the appointment by Gov. Larry Hogan, each will serve a four-year term on the board that oversees the state’s quasi-public agency backing early-stage tech companies.

Cambridge life sciences cluster set to deliver additional £1billion to the UK economy by 2032 – Cambridge Network

The Cambridge life sciences cluster has the potential to contribute an additional £1bn to the UK economy by 2032, according to independent research commissioned by AstraZeneca.

NIST wants public insight on how to streamline R&D collaboration

The National Institute of Standards and Technology is looking for the public’s help in refreshing how it uses research and development funds to help bring new products to market.

These 6 UMB student teams have big ideas for new companies – Technical.ly Baltimore

Students at UMB are looking to form new startups that will bring change to a range of different areas in healthcare and beyond, from the pockets where nurses keep supplies to the ways that drugs are delivered.

What Is Blockchain? Three Videos Explain the New Technology That Promises to Change Our World | Open Culture

You’ve heard the word “blockchain” many times now, but probably not quite as many as you’ve heard the word “bitcoin.” Yet you surely have a sense that the referents of those two words have a connection, and even if you haven’t yet been interested in either, you may well know that blockchain, a technology, makes Bitcoin, a currency, possible in the first place. Their sheer novelty has already given rise to a mini-industry of explainer videos, more of them dealing directly with bitcoin than blockchain, but in time the latter could potentially overtake the former in importance, to the degree that it becomes as vital to society as the protocols that undergird the internet itself.

Jonathan Aberman: This study shows how cybersecurity can foster economic growth – Washington Business Journal

What does it take to be a founder of a cybersecurity startup in the Greater Washington region? Prior experience, according to a new study from American University’s Kogod School of Business.

Fast-growing Twist Bioscience finds Peninsula expansion space with investor-landlord Alexandria Real Estate Equities (NYSE: ARE) – San Francisco Business Times

When Twist Bioscience Corp. started in Mission Bay five years ago with the idea of making synthetic genes for researchers, it consisted of Emily Leproust and her two co-founders. Today, the 240-employee company is priming to move to nearly 61,000 square feet in South San Francisco.

All You Need to Know for Round 2 of the CRISPR Patent Fight – Scientific American

It’s baaaaack, that reputation-shredding, stock-moving fight to the death over key CRISPR patents. On Monday morning in Washington, D.C., the U.S. Court of Appeals for the Federal Circuit will hear oral arguments in University of California v. Broad Institute. Questions?

HHS Secretary Alex Azar Gives Industry Leaders a Map of the New Healthcare – Healthcare Blogs

It was quite fascinating to cover the speech that Health and Human Services Secretary Alex Azar gave this week in Washington, D.C. In a keynote address on Wednesday morning at the Marriott Wardman Park Hotel, Secretary Azar laid out his agency’s overall policy strategy, for attendees at the World Health Care Congress, which annually gathers together leaders from all the major sectors of the U.S. healthcare industry, from hospitals to physician groups to post-acute and behavioral healthcare, to health plans/health insurers, employer-purchasers, pharmaceutical leaders, and healthcare IT leaders. It’s an ideal venue for senior federal healthcare officials to make announcements—and they usually do show up every year, and sometimes, make news.

As digital health companies proliferate, it’s getting tougher to spot the strongest businesses – MedCity News

The digital health rocket seems to have gotten supercharged lately, at least when it comes to fundraising. Depending on who you ask, either $1.62 billion (Rock Health’s count) or $2.5 billion (Mercom) or $2.8 billion (Startup Health’s count) was plowed into digital health companies in just the first three months of 2018. By any measure Q1 2018 was the most significant quarter yet for digital health funding. This headline has been everywhere. Digital health: to infinity and beyond! But what is the significance of this? Should investors and customers of these companies be excited or worried? It’s a little hard to tell.

9th Call of the U.S.-India Science and Technology Endowment Fund-Introduction

“Commercializing Technologies for Societal Impact”

The governments of the United States of America (through the Department of State) and India (through the Department of Science & Technology) have established the United States – India Science & Technology Endowment Fund (USISTEF) for the promotion of joint activities that would lead to innovation and technopreneurship through the application of science and technology. The Endowment Fund activities are implemented and administered through the bi-national Indo-U.S. Science and Technology Forum (IUSSTF).

May 01 2018

Love0

302nd Edition – May 1, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

May 1, 2018

Galen Robotics Wins BioHealth Capital Region 3rd Annual Crab Trap Competition

Galen Robotics, a Johns Hopkins University spinout, was chosen from five finalists as the company with the most commercial potential by judges at the 3rd Annual Crab Trap Competition. This year’s judges included industry leaders Amgen’s Bethany Mancilla, AstraZeneca’s Shaun Grady, Blu Venture’s Dr. Paul Silber, J.P. Morgan’s John T. Rubin, New Enterprise Associates’ Sara Nayeem, Roche’s Robert Silverman, and Sands Capital Ventures’ Stephen Zachary. They were impressed with a presentation by Lead Hardware Engineer, Yunus Sevimli, on Galen Robotics’ low-cost, compact, and intuitive to use novel microsurgical robotic platform designed to assist surgeons with minimally-invasive applications in otolaryngology, neurosurgery and similar critical fields. Galen Robotics is the third Johns Hopkins University spinout to win this competition following LifeSprout (2017) and Sonavex (2016).

Strong presentations also were made by the other finalists–AlgometRx, Cellth Systems, Renalert, and Reveragen Biopharma—whose technologies originated at Children’s National Medical Center, the University of Maryland, and Johns Hopkins University.

Biohealth Capital Region aiming for top 3 status – Smart Incentives

The Biohealth Capital Region–DC, Maryland and Virginia – plans to be a top 3 biohealth hub in the US by 2023. What will it take to get there?

The Biohealth Capital Region is already a top 5 location as ranked by NIH and venture capital funding, patents, lab space, and jobs. The 1,100 participants at this week’s 2018 Biohealth Capital Region Forum agreed on the area’s strengths: a highly educated and diverse workforce, leading universities and research institutions, strong healthcare organizations, hundreds of companies, and broad-based policy commitment to the biohealth industry.

Job Opportunity: University of Maryland, College Park Seeks Director, Office of Technology Commercialization – IPWatchdog.com

The University of Maryland, College Park is seeking a Director for its Office of Technology Commercialization. The Director leads and manages the OTC, overseeing personnel, budgets, and all aspects of intellectual property cultivation, assessment, protection, and commercialization. The Director establishes and implements strategies to maximize the social and economic impact of University research and discoveries through OTC’s commercialization efforts and its support of related entrepreneurial endeavors. The Director is responsible for developing and meeting annual OTC licensing goals and acts as primary point of contact and steward to resolve problems and issues affecting intellectual property and licensing at all levels within the University.

The genomics-focused Illumina Accelerator backs five new companies – TechCrunch

Illumina Accelerator, the genomics-focused startup accelerator backed by the publicly traded genetic sequencing pioneer Illumina Corp., has picked five startups for its seventh accelerator class, the company announced.

Wth technology addressing skin microbial therapeutics, fertility science, chronic disease alleviation, post traumatic stress disorder treatments, and services for the biopharmaceutical and clinical research industries; the startups selected by Illumina will have access to the company’s genomics and sequencing expertise, business coaching, lab and office space and an infusion of capital.

BioHealth Capital Region Industry Compensation Survey™

Is your employee compensation package competitive?

Help us help you. Complete the 2018 BHCR Industry Compensation Survey by June 1, 2018 to receive an anonymized summary of salaries and benefits specific to positions in biohealth and to this region. A pdf version of the survey is available here or you can use the online version of the survey to complete your information. All company specific information will be kept confidential. This survey is a joint project among BioHealth Innovation, WorkSource Montgomery, and UMBC-Shady Grove’s Industrial Organizational Pyschology Program. If you or your Human Resources colleagues have any questions about the survey, please contact BHI@BioHealthInnovation.org.

NIH-Funded Research Finds emocha Medication Adherence Technology Leads to Cost Savings | emocha Mobile Health

emocha Mobile Health’s video Directly Observed Therapy (DOT) platform helped patients with tuberculosis achieve 94 percent medication adherence with the potential to save public health programs $1,391 per patient on average, according to a new study conducted by researchers at the Johns Hopkins University School of Medicine published today in Open Forum Infectious Diseases. Staff and patients cited increased flexibility, convenience, and patient privacy compared to traditional treatment methods.

This startup is bringing a human face to surgical masks – Technical.ly Baltimore

A few years ago, Allysa Dittmar was about to go into surgery, but her interpreter didn’t show up.

Dittmar, who is deaf, was able to lip-read and recognize facial expressions during some of the mandated check that’s required before a procedure, but those were obscured when surgeons, nurses and anaesthesiologists, put on their masks. Things grew more frustrating, and the staff eventually gave up trying.

Christy Wyskiel Named to BBJ’s Power 10

The Baltimore Business Journal recognized Christy Wyskiel for her ongoing efforts to perfect the “magic formula” that will further catalyze the commercialization of life-changing research and technologies emerging from labs and dorms across Johns Hopkins.

United Therapeutics To Acquire SteadyMed Ltd.

United Therapeutics Corporation (NASDAQ: UTHR) and SteadyMed Ltd. (NASDAQ: STDY) announced today the signing of a definitive merger agreement under which United Therapeutics will acquire SteadyMed for $4.46 per share in cash at closing and an additional $2.63 per share in cash upon the achievement of a milestone related to the commercialization of Trevyent®. The transaction, including the $75 million in contingent consideration, is valued at $216 million.

Ben Jealous brought Google and Alphabet execs to Maryland – Technical.ly Baltimore

Gubernatorial candidate Ben Jealous organized a meeting on Thursday that gave executives from Google and parent company Alphabet a chance to hear about technology in Baltimore and Prince George’s County.

These Greater Washington women scored big venture capital deals — that’s far too rare – Washington Business Journal

Women and minorities are sparsely represented in our recent fundings. So what do we do about that?

Angel deals see big increase in female firms and greater geographic diversity, according to HALO Report | SSTI

In 2017, 25.7 percent of all angel capital group deals went to a founding team with at least one female founder, up from 17.0 percent in 2016, according to the Angel Resource Institute’s (ARI) HALO Report: 2017. The report also found a sizeable increase in the number of deals made for companies that included at least one minority female founder – 5.5 percent in 2017 (1.0 percent in 2016).

How to bet and win on biosciences … outside established hubs – PE Hub

San Diego. New Haven. Boston.

Besides cities that make for a nice waterside vacation, these destinations seem to have figured out the complex, yet irresistible, world of bioscience investment.

To create jobs, think long term – fredericknewspost.com

As a business owner, I’m often asked to speak to groups about my entrepreneurial journey. One component of my talk involves the importance of long-term thinking. Too often, businesses and politicians fall into the trap of short-term thinking. They focus on making a profit this quarter or succeeding in their re-election campaign without considering the impact of their decisions five, 10 or 20 years down the road.

Bill Gates Just Announced a $12 Million Grand Challenge for a Universal Flu Vaccine

The real world isn’t like Hollywood. Despite what we might see in TV shows like 24 or movies like Contagion, we don’t have teams of experts ready to spring into action at the first signs of a global outbreak.

But we should, philanthropist Bill Gates emphasized during his Shattuck Lecture for the Massachusetts Medical Society today. And Gates is ready to put up $12 million to help us get there.

Augmented-reality system lets doctors see medical images projected on patients’ skin | Kurzweil

New technology is bringing the power of augmented reality into clinical practice. The system, called ProjectDR, shows clinicians 3D medical images such as CT scans and MRI data, projected directly on a patient’s skin.

New immunotherapy treatment for lung cancer dramatically improves survival, researchers report | Kurzweil

An immunotherapy treatment — one that boosts the immune system — has improved survival in people newly diagnosed with the most common form of lung cancer (advanced non–small-cell lung cancer), according to an open-access study published in the New England Journal of Medicine.

REGULATORY APPLICATIONS OF REAL WORLD EVIDENCE

Real-World Evidence (RWE) holds out the promise of reducing time and costs of product approvals, identifying new uses for existing products, increasing our ability to treat rare diseases, and improving clinical practices for using drugs and medical devices. The 21st Century Cures Act, enacted in 2016, requires FDA to evaluate the use of RWE in approving new drug indications. FDA in 2017 issued a final guidance document regarding RWE in regulatory decisions involving medical devices. The private sector is also focusing on RWE: more than half the pharmaceutical companies in a recent survey say they are significantly expanding their involvement in RWE. Nonetheless, misunderstandings and uncertainties remain, both about what constitutes RWE and its potential role in regulatory and other aspects of precision medicine.

Apr 26 2018

Love0

301st Edition – April 26, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

April 26, 2018

BHI CEO Rich Bendis’ Opening Presentation at The 2018 BioHeath Capital Region Forum

Welcome to the 2018 BioHealth Capital Region Forum: State of the BioHealth Capital Region’s EcoSystem

Presented by: Rich Bendis, President & CEO, BioHealth Innovation Inc.

Message at BioHealth forum: Md., Va., and D.C. biotech industry needs to get rid of silos – Baltimore Business Journal

The annual BioHealth forum brought together about 1,100 biotech industry stakeholders from across Maryland, Washington, D.C., and Virginia.

University presidents Loh, Perman on impact of immigration changes to STEM workforce – Baltimore Business Journal

George Mason University President Angel Cabrera said more restrictive immigration policies could threaten the future of regional and national biotechnology industries.

“It is critical for universities to act both as producers of [science, technology, engineering and math] talent and as magnets for top STEM faculty and researchers from around the world. That is our biggest role in the ecosystem,” Cabrera said. “When we mess with immigration policy, our whole system of science and innovation is at stake.

BioHealth Capital Region Industry Compensation Survey™

Is your employee compensation package competitive?

Corvidia Therapeutics Secures $60 Million in Series B Funding to Accelerate Clinical Work | Business Wire

Corvidia Therapeutics Inc., a leading clinical stage biotechnology company, today announced the close of a $60 million USD Series B funding round. The financing will accelerate growth of Corvidia’s ongoing clinical programs, expand scientific and market access capabilities and explore new treatment areas.

Emmes Launches New Internship Program with an Egyptian Children’s Cancer Hospital

The Emmes Corporation today announced the creation of an internship program in which the company will offer one fellow from Egypt’s Children Cancer Hospital an internship to gain training and experience in clinical research. Under the new program, one fellow will be selected each year to travel to Emmes’ headquarters in Rockville, Maryland, to work with its clinical research experts. The duration of each internship will be determined on a case-by-case basis.

QIAGEN Announces FDA Approval of PartoSureTM – Business Wire

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory approval of PartoSureTM , which is a novel test for assessing the risk of spontaneous preterm birth in patients with symptoms of preterm labor. The pre-market approval of PartoSure by the U.S. Food and Drug Administration (FDA) follows successful uptake of the rapid, accurate test in more than 35 countries across Europe, the Middle East, Asia and Latin America. U.S. commercialization of the PartoSure test is expected to begin in 2018.

New Enterprise Associates the most active venture firm in Q1 2018

The first quarter of 2018 saw a decline in investments, given that global deal activity decreased by 4 percent. Despite the fewer deals, global investment reached $46.5 billion, invested across 2,884 deals. The data was revealed as part of a larger report titled Money Tree, put together by CB Insights and PricewaterhouseCoopers, with focus on the latest trends in venture capital funding globally.

Why you need to know NEA’s Scott Frederick – Washington Business Journal

He is a walking Rolodex of some of the nation’s most high-powered business leaders. And he’s the reason many startups feel they’ve gotten a leg up in an otherwise crushing entrepreneurial race.

Maryland Biotechs Dominate 2018 Vaccine Industry Excellence Awards – BioBuzz

More than a dozen biotech companies or researchers from the Maryland biotech cluster, which some have also dubbed ‘Vaccine Alley’, were among the most recognized finalists at this year’s Vaccine Industry Excellence (ViE) Awards in Washington, DC at the World Vaccine Conference. In fact, 15 out of the 54 finalists, or 27%. were from right here in Maryland. This year’s conference was held in Washington, DC so could this have been a case of home court advantage? Probably not. More than likely it’s because this region holds 20% of the top influencers worldwide in vaccine development.

FounderTrac’s First of Two Cohorts in 2018 Was a Standing Room Only Event with Aimee Martin of MileMarker Winning a $25k Investment from MCVC Partners! | Business Wire

On Tuesday, April 3, 2018 TEDCO Incubation Challenge finalist FounderTrac had their first Demo Day at Host Sponsor Loews Annapolis Hotel. After a 12 week, rigorous program 10 FounderTrac finalists pitched to a standing room only atrium of over 200 attendees. Over 50 angel investors and venture capitalists were in attendance creating an energy at the event that truly represents the essence of entrepreneurship. Tami Howie, CEO of the Maryland Technology Council says, “We had a huge number of high quality investors attend our showcase to see the amazing growth of our companies over the last 12 weeks of our FounderTrac program.”

CARB-X 2018 Funds

Are you involved in the fight against drug resistant bacteria? Between June 1 and June 8th, organizations seeking funding to advance antimicrobial technologies (diagnostics, therapeutics or devices) will have the opportunity to submit Expressions of Interest (EOI) to CARB-X. CARB-X is dedicated to accelerating global antibacterial innovation through targeted funding of focused projects. Only technologies specifically focused on the Pathogens outlined in the CARB-X 2018 Funding Round 2 Scope will be considered. Now is the time to beginning preparing your EOI. More information is available on the CARB-X website: http://www.carb-x.org/application

MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief Medical Officer

MaxCyte, the global cell-based medicines and life sciences company, announced today that it has appointed Claudio Dansky Ullmann, MD, a 25+-year expert in clinical oncology and pharmaceutical research, as its Chief Medical Officer (CMO). In his new role, Dr. Dansky Ullmann is responsible for overseeing clinical development of MaxCyte’s CARMA™ drug development program as the company’s first candidate, MCY-M11, is expected to enter the clinic this year.

Commercialization Brings Research with ‘Broad Benefits’ to Market – GW Today

Patients dealing with hypotension, or dangerously low blood pressure, can now be treated with a drug initially developed by George Washington University researcher Lakhmir Chawla from the School of Medicine and Health Sciences and the GW Medical Faculty Associates.

Science Start-Ups Gain Strong Momentum at the Prince William Science Accelerator – pilotonline.com

Prince William County today congratulated three science start-ups – ISOThrive, LLC, Virongy, LLC and Ceres Nanosciences, Inc., – on recent business successes leading from the Prince William Science Accelerator.

How New York VC firm Deerfield Management plans to help Johns Hopkins bring more products to market – Baltimore Business Journal

New York investment firm Deerfield Management is looking to bring more drugs, medical devices and health care products to market by partnering with academic institutions like Johns Hopkins University.

Chinese money floods US biotech as Beijing chases new cures | afr.com

Chinese investors are pumping money into US drug startups as Beijing seeks to become a global leader in new medicines, adding to a flood of cash flowing to groundbreaking health firms.

New Members Join NIIMBL to Advance Biomanufacturing

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a proud member of Manufacturing USA® is pleased to welcome Genentech, Celgene, Merck, MilliporeSigma and EMD Serono (the U.S. businesses of Merck KGaA, Darmstadt, Germany), among others, to its growing membership base.

A ‘groundbreaking’ day: Workers break ground on new science complex

Towson University celebrated the start of construction on the new science complex with a groundbreaking ceremony on the top floor of the Glen Garage April 17.

Construction for the new science complex began in fall 2017, but the ceremony marked the University officially breaking ground on the project.

Global Cities Challenge America’s High-Tech Dominance – CityLab

We hear a lot these days about the so-called “rise of the rest”—the ascent of second-tier American cities such as Pittsburgh, St. Louis, Detroit, and Nashville as challengers to the established tech capitals of the Bay Area, New York, Boston, and Seattle. But the reality is that the rise of the rest is happening mainly in cities outside of the United States.

Apr 17 2018

Love0

300th Edition – April 17, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

April 17, 2018

Last Week to Register: BHCR Forum 2018 – HHS Secretary Alex M. Azar II Confirmed

Don’t let your colleagues miss out — Forward this message to other senior leadership in the Region to invite them to attend the 2018 BioHealth Capital Region Forum. Register with the password: bhcrforum18

The Planning Committee has recently confirmed the participation of Secretary of Health & Human Services, Alex M. Azar II as a keynote speaker. His presentation is an exciting addition to an already robust lineup of speakers.

Check out the BioHealth Capital Region Forum website for regular updates on confirmed speakers and Forum agenda. Download our event application to interact with other attendees and post to the social wall – search for BHCR Forum 2018 in the AppStore or Google Play Store.

Finalists Selected – 3rd Annual BioHealth Capital Region Crab Trap Competition

– Winner to be announced during 2018 BioHealth Capital Region Forum –

Five companies have been selected to present to a panel of investor judges and an audience of industry leaders during the 2018 BioHealth Capital Region Forum, April 23-24, at the MedImmune campus in Gaithersburg, Maryland. Founded by BioHealth Innovation, Inc. (BHI) and MedImmune in 2016, the annual Crab Trap Competition highlights companies from throughout the region in varied stages of business development and industry sectors. Open to applicants from Maryland, DC and Virginia, previous winners are Johns Hopkins University spinouts: LifeSprout (2017) developing the next-generation of synthetic soft tissue substitutes for aesthetic and reconstructive medicine, and Sonavex (2016), developer of a pipeline of novel ultrasound solutions to visualize and quantify critical clinical data for improved outcomes and reduced costs in new surgical applications. The 3rd Annual Crab Trap Competition is sponsored by Wilson Sonsini Goodrich & Rosati. The grand prize includes $10,000, incubation space in either Montgomery County, MD or Prince William County, VA, and business mentoring.

BHI Portfolio Company MIMETAS Secures 20 Million Dollar Series B Financing – Mimetas

MIMETAS, leader in organ-on-a-chip products and tissue models, has secured 20.5 million USD in financing from an international syndicate from Asia and Europe. Mimetas will use the proceeds of this Series B financing round to expand its global commercial footprint with the OrganoPlate® organ-on-a-chip platform. In addition, the company will broaden its product portfolio, establish tissue production facilities, develop novel OrganoPlate® products and expand into clinical market segments, including personalized medicine. The company has operations in the Netherlands, USA and Japan.

MedImmune spinoff Viela Bio leads Greater Washington to stellar VC funding quarter, per Pitchbook – Washington Business Journal

The D.C. area saw its biggest first quarter in startup funding in at least 16 years, with companies raking in more than $473.3 million in venture capital with the biotech and software sectors leading the way, according to data provided by PitchBook.

The 2018 Maryland Health Impact Forum – May 15th – 16th, 2018

New York-based Cavendish Global (URL: http://cavendishglobal.com), together with the University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR), MedImmune (a member of the AstraZeneca Group), BioHealth Innovation, and BioHealth Capital Region will co-host Cavendish’s sixteenth Health Impact Forum, and the first in the state of Maryland, on May 15th and 16th, at the Chevy Chase Club and IBBR. Cavendish is a by-invitation-only community of select health and life science innovators and researchers, impact investors (single and multi-family offices, foundations, philanthropists, angel investors and pro-social private equity and venture capital investors), along with renowned institutional, nonprofit and public leaders. Cavendish members convene throughout the year at Health Impact Forums held in diverse innovation hubs, to identify, showcase and support the leading innovators addressing health’s greatest unmet needs. To request an invitation:http://cavendishglobal.com/invitation-request

Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries

Emergent BioSolutions Inc. (NYSE:EBS) today announced the successful completion of the Mutual Recognition Procedure (MRP) for market authorization of BioThrax® (Anthrax Vaccine Adsorbed) in five Concerned Member States (CMS) within the European Union (EU), including Italy, the Netherlands, Poland, the U.K., and France (where it will be marketed as BaciThrax™). Emergent filed the mutual recognition application based on the existing Marketing Authorization of BioThrax in Germany granted by the Paul-Ehrlich-Institut. Following the positive MRP outcome, national licenses are due to be issued shortly by the five CMS countries.

Alexandria LaunchLabs, the Premier Life Science Startup Platform, to Open in Fall 2018 at the

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, today announced the expansion of Alexandria LaunchLabs®—its premier, full-service life science startup platform—into the thriving East Cambridge life science ecosystem. Alexandria LaunchLabs will open in the fall of 2018 in One Kendall Square, one of the most sought-after locations for life science companies in the United States. Building upon the success of Alexandria LaunchLabs’ initial flagship site, which opened at the Alexandria Center® for Life Science – New York City in June 2017, the company will now bring its validated Alexandria LaunchLabs platform to Cambridge to meet the cluster’s critical demand for life science startup space.

Building up the BioHealth Capital Region – FederalNewsRadio.com interview with BHI CEO Rich Bendis

What’s Working in Washington EXTRA is an opportunity for us to discuss an issue of particular interest to the region. We’re talking today about life science, biotechnology, medical devices, and how these industries are successful and well-represented represented here in the D.C. region. Joining us to discuss the growth of these sectors are two experts: Richard Bendis, president & CEO of BioHealth Innovation Incorporated, and Jeff Gallagher, CEO of Virginia Biotechnology Association, or VABio.

HGMD enables you to provide better care with better knowledge! – White Paper

In 2016, a mother filed a lawsuit relating to the death of her son Christian against a diagnostic company. When Christian began experiencing a series of unrelenting seizures, the company performed a massive battery of tests, including the sequencing of a gene called SCN1A. At the time, the company reported that he had a variant of unknown significance (VUS) there. What the company did not realize was that there was a peer-reviewed study that had identified the same SCN1A mutation in an Australian family one year earlier. Christian received inappropriate treatment and died from a seizure months later.

TEDCO 2.0 initiative rolls out new funding, programming efforts for Md. startups – Baltimore Business Journal

TEDCO CEO George Davis has spent several months in his new role traveling the state and talking to startups and other tech industry players, trying to figure out how his organization can best serve Maryland’s entrepreneurial community beyond what it has been doing for the past 20 years.

Hopkins teams with Lockheed Martin to enhance STEM programming for Baltimore students | Hub

The Johns Hopkins University and Lockheed Martin today announced a partnership aimed at enhancing opportunities for Baltimore City public school students pursuing academic and career fields in science, technology, engineering, and math. The collaboration is designed to close the STEM gap that exists primarily in Pre-K through 12th grade.

NHLBI 70th Anniversary Lecture Series

This year marks the 70th Anniversary of the National Heart, Lung, and Blood Institute (NHLBI). NHLBI began as the National Heart Institute on June 16, 1948, when President Harry S. Truman signed the National Heart Act. In 1969, the Institute expanded its mission (and name) to cover research on lung diseases, and in 1976, the Institute grew further to include blood disorders.

To commemorate the Institute’s 70th anniversary and showcase important investments in scientific research, NHLBI is featuring lectures throughout the year from prominent thought leaders representing areas of high scientific priority in heart, lung, blood, and sleep disorders.

Epidarex-backed Enterprise Therapeutics raises £29 million (USD$41 million) funding

Enterprise Therapeutics Ltd, a biopharmaceutical company dedicated to the research and development of novel therapies for the treatment of respiratory diseases, today announced that it has closed an oversubscribed £29 million ($41 million USD) Series B round co-led by Versant Ventures and Novartis Venture Fund. The syndicate also included new investor Forbion, founding investor Epidarex Capital and existing investor IP Group.

New Enterprise Associates, Y Combinator, Khosla Ventures, Andreessen Horowitz, GV and Greycroft top ranking of most active Q1 venture investors – Silicon Valley Business Journal

Y Combinator has broadened its investment focus beyond the seed funding it gives to startups in its accelerator batches, and has become one of the most active investors in the country in subsequent stages.

GSK divests line of rare disease drugs

GlaxoSmithKline divested its portfolio of rare disease gene therapies to Orchard Therapeutics through a strategic agreement, the company announced April 12.

First annual Kendall Square Challenge to take place May 17 – News – Cambridge Chronicle & Tab – Cambridge, MA

The first annual Kendall Square Challenge, an app-driven fundraiser competition benefiting various nonprofits, will take place May 17 in Cambridge.

Apr 10 2018

Love0

299th Edition – April 10, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

April 10, 2018

Third Annual Crab Trap: Finalists Announced Tomorrow

You thought the Shark Tank was tough…

wait until the BioHealth Capital Region Crab Trap!

Five finalists will have a chance to win the grand prize by presenting infront of a panel of prominent industry funding experts and executives including:

Rich Bendis (Moderator), President & CEO, BioHealth Innovation, Inc.
Christian Barrow, Executive Director, Life Sciences, J.P. Morgan
Shaun Grady, VP, Strategic Partnering & Business Development, AstraZeneca
Sara Nayeem, Partner, New Enterprise Associates (NEA)
Dr. Paul Silber, Founding Principal, Blu Venture Investors
Robert Silverman, Head Externalized Drug Discovery Partnering, Roche
Stephen Zachary, Associate, Sands Capital Ventures

Christy Wyskiel, Senior Advisor to the President at Johns Hopkins University, chats with host Rich Bendis for new episode of BioTalk

Christy Wyskiel, an investor, entrepreneur, and ecosystem builder, serves as Senior Advisor to President Daniels at Johns Hopkins University. She runs the group Johns Hopkins Technology Ventures, which serves as the tech transfer, corporate partnership, and start-up arm of the university. In this episode of BioTalk, Christy and Rich discuss Tech Transfer, Innovation, Investment, Partnerships, Collaborations, and other important areas that she and JHU work on every day.

Listen now on iTunes , Google Play , and TuneIn.

24 most active nonprofit, public or university investment funds identified – TEDCO Recognized – SSTI

In reviewing data regarding the hundreds of TBED-related investment funds, SSTI found that 24 of them have invested in at least one dozen startups each over the past year. The funds are characterized as economic development, university-centric, regionally focused, or impact oriented investment funds, incubators and accelerator programs located in the U.S. or Canada. Data the various funds provide to Pitchbook is the source of the list below, ranked in order by activity level. Each organization may have used their public or university funding to support operations, due diligence or mentoring of portfolio companies and/or to support direct invest into startups. University-centered activities in the list are denoted by an asterisk at the end of the entry. Two of the most active 24 funds are nonprofit, impact accelerators supported in part by foundations and corporation philanthropy.

CASI Pharmaceuticals’ Evomela Moves Closer to China FDA Approval with Receipt of Advisory Meeting Notice from China Center for Drug Evaluation

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces receipt of a letter from the Center for Drug Evaluation (CDE) (group within the China FDA in charge of technical review) indicating that EVOMELA® (melphalan) for injection has been scheduled for review by the Expert Advisory Anti-Tumor (Oncology) Drugs Committee (the “Advisory Committee”), which is scheduled to take place between April 25-26, 2018 (the “Advisory Committee Meeting”).

2018 BioHealth Capital Region Forum: Only 1 Week Left to Register

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland and MedImmune/AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

How a local scientist became an accidental entrepreneur – FederalNewsRadio.com

Contrary to popular belief, the D.C. region can be a dynamic place to start a life science business. Many things that we are now taking for granted from the standpoint of healthcare and life extension, are happening, and were developed, here in our region. One example of that is our next guest, David Cetlin, founder of MockV Solutions, a startup that’s growing through revenue in the area.

WellDoc Announces Providence Health & Services’ Implementation of BlueStar® Digital Therapeutic in a Pilot Program for Individuals with Type 2 Diabetes

Today, WellDoc® announced a pilot program in the Providence Health & Services Oregon/SW Washington Region to examine the use of WellDoc’s BlueStar®, an FDA-cleared, proven digital therapeutic for individuals with type 2 diabetes. The Providence Health & Services pilot program will include individuals living with type 2 diabetes and will evaluate the impact of a digital therapeutic—when used in conjunction with the support of a dedicated Diabetes Educator—on user engagement, retention, satisfaction and clinical outcomes.

Gliknik Announces Issuance of U.S. Patent for Use of Recombinant IVIG Mimetics

Gliknik Inc. today announced that the U.S. Patent & Trademark Office (PTO) has issued U.S. Patent 9,926,362, which claims methods of using compounds that have utility as recombinant mimetics of pooled human intravenous immunoglobulin (IVIG). The patent, which issued jointly to Gliknik Inc. and to the University of Maryland, Baltimore (UMB), encompasses the uses of trimers, tetramers, pentamers, hexamers, and many other structures containing two or more human IgG1 Fc domains and binding multiple low affinity Fc gamma receptors (FcγRs).

Compugen signs cancer drug licensing deal worth up to $200m

MedImmune, the R&D arm of AstraZeneca, will make an immediate payment of $10 million to the Israeli cancer immunotherapy company. Israeli cancer immunotherapy company Compugen Ltd. (Nasdaq: CGEN; TASE: CGEN) today announced that it has entered into an exclusive license agreement with MedImmune, the biologics R&D arm of AstraZeneca. The agreement will facilitate the development of bi-specific and multi-specific immuno-oncology antibody products.

Apply now for Maryland Incubator Company of the Year Awards. Deadline: April 18th

The 2018 Maryland Incubator Company of the Year Awards publicly recognizes achievements by current clients and graduates of Maryland incubators and provides a forum for the nominees to increase their visibility in the business, technology and investment communities.

Business incubators support new and early-stage businesses in Maryland. In 1986, the first public incubator was established at the University of Maryland in College Park. Recognizing the economic challenges facing new companies, business incubators are facilities that provide reasonable market rents, shared services and technical assistance to start-ups and early-stage companies, including manufacturing, biotech, service and technology firms.

Immunomedics Appoints Dr. Robert Iannone Head of Research & Development and Chief Medical Officer

Immunomedics, Inc., (NASDAQ:IMMU) (“Immunomedics” or the “Company”), a leader in the field of antibody-drug conjugates (ADCs), today announced the appointment of Robert Iannone, M.D., M.S.C.E., as Head of Research & Development and Chief Medical Officer, effective today. In his new role, Dr. Iannone will oversee and lead all clinical development, regulatory, pre-clinical, translational research and medical affairs strategies and activities of the Company. Dr. Iannone brings more than thirteen years of experience in clinical drug development, including the approval of several targeted and immuno-oncology medicines at AstraZeneca/MedImmune and Merck & Co.

MIPS Funding Available: Apply by May 1, 2018

Accelerate tech product development with MIPS funding.

The Maryland Industrial Partnerships (MIPS) program provides funding for university research projects that help companies develop new technology products.

Division of Industrial Innovation & Partnerships – Division Director Employment Opportunity – National Science Foundation

The National Science Foundation’s Directorate for Engineering (ENG) announces a nationwide search to fill the position of Division Director (DD), Industrial Innovation and Partnerships (IIP). The position provides an unparalleled opportunity to lead the Division to support research, innovation, and entrepreneurship at the forefront of advancing knowledge and stimulating translation of new knowledge into solutions that benefit society; to share in the management responsibility of the Directorate for Engineering to advance NSF’s overall strategic goals “to expand knowledge in science, engineering, and learning, to advance the capability of the nation to meet current and future challenges, and to enhance NSF’s performance of its mission.”

FounderTrac closes out with demo day in Annapolis – Technical.ly Baltimore

At the Loews Annapolis Hotel on Tuesday night, ten founders took the stage.

They were gathered before a full audience of tech community members to pitch and close out FounderTrac, the Annapolis-based program which ran over 12 weeks to start the year. Throughout, the founders went through a curriculum to help build their business and were guided by “Executive Sherpas,” who offered mentorship.

Win Funding for Your Innovative Research – Enter Today! – SoBran, Inc.

Deadline to apply is April 17, 2018

The Maryland Tech Council and SoBran are celebrating the transformational science coming out of Maryland and surrounding area by establishing the Innovation for Impact Prize. This is an added annual award at the Industry Awards Celebration. Tell us how your innovative research will impact the world one day and describe your research!

It is our pleasure to host the Summer RISE program again this year. We had some amazing students last year and we look forward to the next group of rising stars.” – Darlene Douglas, Summer RISE 2017 Host“

GE Sheds Health IT Assets for $1B, Doubles Down on A.I. and Devices – Xconomy

General Electric is selling a chunk of its healthcare IT business to New York private equity firm Veritas Capital for $1.05 billion in cash, as GE (NYSE: GE) chief executive John Flannery aims to streamline the Boston-based industrial behemoth and reverse a steep decline in its stock price.

Former USM Chancellor Brit Kirwan said to be competitive, Marylanders need to care about quality of schools in every county – Baltimore Business Journal

The Kirwan Commission hopes investing in initiatives like full-day preschool and intensified teacher preparation training will help Maryland schools become competitive on an international level.

Abell Foundation, University System of Maryland lead $1.45 million round for aerospace startup – Baltimore Business Journal

An aerospace company born out of the University of Maryland, College Park has raised $1.45 million in a round led by the University System of Maryland and the Abell Foundation.

Aisling Capital’s Steve Elms on rise of massive early funding rounds – Business Insider

Funding has been flowing into biotech over the past few years.

Over one week earlier this year, biotech and healthcare startups raised almost $1 billion in capital. And on Tuesday, a cancer-drug startup called Allogene raised $300 million in its series A round.

Private equity firm Alvarez & Marsal Capital acquires majority stake in CNSI Inc. – Washington Business Journal

Federal health IT contractor CNSI has sold a majority interest in the company to Alvarez & Marsal Capital, a middle-market private equity firm.

Financial terms of the deal weren’t disclosed.

Just 3 Weeks Away! Is your Intellectual Property protected?

Safeguard Your Intellectual Property Internationally & in the U.S. Learn about IP and how to protect it Online, while Exporting and at Trade Shows

This is an opportunity to learn the basics of IPR protection and U.S. government resources available to help you protect your IPR at home and abroad.

Apr 08 2018

Love0

298th Edition – April 3, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

April 3, 2018

Office of Montgomery County Executive Assistant Chief Administrative Officer Lily Qi Interviewed on BioTalk with Rich Bendis Podcast

Lily, Qi, Assistant Chief Administrative Officer – Office of Montgomery County Executive joins Rich for this episode of BioTalk. They discuss the topics like the role that MoCo plays in Economic Development, Cultural Competence in a diverse region, and her future career goals. Lily has served County Executive Ike Leggett for eight years in various capacities and led strategic initiatives including privatizing economic development functions; establishing BioHealth Innovation, Inc. to advance research commercialization; developing global partnerships; improving nighttime economy, and developing the Comprehensive Economic Strategy. Lily joined Montgomery County after serving as Vice President of Business Development and Marketing for the Washington, DC Economic Partnership and spokesperson for the DC Department of Insurance, Securities and Banking.

Listen now on iTunes , Google Play , and TuneIn.

Third Annual Crab Trap: Deadline approaching, last week to apply….

APPLY NOW »

You thought the Shark Tank was tough?

The Third Annual BioHealth Capital Region Crab Trap is now accepting applications at http://www.bhcrforum.com/crab-trap/

Deadline for entries is April 9th, 2018 – Finalists will be announced on April 17th, 2018

Submit your application for a chance to be named the startup company with the most commercial potential at the BioHealth Capital Region Forum.

Five finalists will have the chance to win the grand prize by presenting on April 24th in front of a panel of prominent industry funding expert and executives.

2018 BioHealth Capital Region Forum: Only 2 Weeks Left to Register

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

2018 FNIH Lurie Prize in Biomedical Sciences Winner Discovered How DNA Stimulates Immune Response

The Foundation for the National Institutes of Health (FNIH) is delighted to recognize Zhijian “James” Chen, Ph.D., with the 2018 Lurie Prize in Biomedical Sciences for discovery of the enzyme cyclic GMP‐AMP synthase (cGAS) and its corresponding pathway, which solved a century- old mystery about DNA. Long before DNA was known to be a genetic material, scientists knew that it could activate the body’s immune system to fight infections. However, they did not understand the cellular process that occurred to trigger this response until Dr. Chen’s discovery. The cGAS enzyme and its DNA-sensing pathway are the catalyst for the critical immune response that defends the body against viruses, bacteria and tumors, but surprisingly, they also can inflict autoimmune disease. Now in its sixth year, the Lurie Prize in Biomedical Sciences will be presented to Dr. Chen at the FNIH Award Ceremony hosted by CNN’s Wolf Blitzer on May 16, 2018 in Washington, D.C.

Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection | Altimmune, Inc.

Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced positive data from its Phase 2a study of NasoVAX intranasal influenza vaccine and provided an update on its Phase 1b study of HepTcell targeted immunotherapy in chronic hepatitis B infection. Results from the Phase 2a study of NasoVAX™ intranasal flu vaccine in 60 healthy individuals showed 100% seroprotection in the mid- and high-dose groups. Results from the Phase 1b study of HepTCell in hepatitis B infection showed that HepTcell was well tolerated at all doses tested, while the unblinded T-cell immunogenicity results were inconclusive.

Center for Human Genomic Medicine and Research Joins JHU Montgomery County Campus – News – Johns Hopkins University Montgomery County Campus

Dr. Sisir Dutta, a former genetics professor at Howard University, has established the Center for Human Genomic Medicine and Research. The nonprofit center is a new tenant at the Johns Hopkins University Montgomery County Campus.

Cerecor Appoints Peter Greenleaf as Chief Executive Officer – Press Release – Digital Journal

Cerecor, Inc. (NASDAQ: CERC) today announced that its Board of Directors has appointed Peter Greenleaf as Chief Executive Officer. Mr. Greenleaf has served on the Company’s board since May 2017. He brings to Cerecor over two decades of biopharmaceutical experience, having most recently served as Chairman and CEO of Sucampo Pharmaceuticals and led the company’s acquisition by Mallinckrodt Pharmaceuticals for $1.2 billion. Throughout his career, Mr. Greenleaf has demonstrated a track record for creating shareholder value through solid commercial execution and efficient drug development.

BioMarker Strategies Announces that Both of Its Core Diagnostics Technologies for Solid Tumor Cancers Are Now Covered by New Patents Granted in Canada | Business Wire

The SnapPath® Cancer Diagnostics System is the only diagnostics system that can generate purified populations of live solid tumor cells from live, unfixed samples in an automated and standardized manner. SnapPath preserves the molecular integrity of these living cells for exposure outside the human body to targeted therapies. This enables the generation of PathMap® Functional Signaling Profiles, which are highly predictive of individual solid tumor response to targeted therapies and combinations, because they are based on the dynamic, predictive signaling information available only from live cells. BioMarker Strategies has been granted patents on both of these important technologies in the United States, Europe, Australia, Canada and Japan, and patent applications are pending elsewhere. (Photo: Business Wire)

Emmes and IDx Partner Using Artificial Intelligence to Detect Diabetic Retinopathy in Primary Care

The Emmes Corporation today announced the completion of a pivotal clinical trial for a new product developed by IDx that could help in detecting diabetic retinopathy, the leading cause of blindness in the United States. IDx-DR is a fully autonomous AI-based diagnostic system that analyzes images of the retina for signs of diabetic retinopathy, providing instructions for follow-up care based on the level of disease detected. IDx-DR has been granted expedited review by the Food and Drug Administration.

2017 Year-End Market Report — MCEDC

Montgomery County continues to experience a steady rise in employment since 2014, a positive change from stagnant growth in prior years. Montgomery County recorded over 550,000 employees, an increase of 2.6% from last year and trended above the then year average of 516,360. Montgomery County’s unemployment rate continued to contract and ended Q3 2017 with a rate of 3.2%, down from 3.3% from November 2016.

BioBuzz with Hogans Agency, Inc. – April 19th

Join BioBuzz and founding sponsor Hogans Agency at Bar Louie on April 19th. Hogans Agency, Inc. has more than 60 years of insurance industry experience and over 20 years experience serving the Life Science insurance segment. We draw upon this expertise as we work to understand the changing nature of our client’s business.

Emergent BioSolutions Announces Executive Management Changes That Enhance Execution of Company’s Growth Strategy NYSE:EBS

Emergent BioSolutions Inc. (NYSE:EBS) today announced executive management changes that continue to align its organizational structure to its long-term strategy and to the achievement of its near- and long-term growth objectives. Specifically, effective today, the company’s board of directors promoted Robert G. Kramer Sr. to the newly-created position of president and chief operating officer, and appointed Richard S. Lindahl as the company’s new executive vice president and chief financial officer.

NexImmune Announces Management and Board Appointments

NexImmune, an emerging leader in the field of antigen-directed immunotherapy, today announced that Scott Carmer has been appointed Chief Executive Officer. Mr. Carmer has served as NexImmune’s Chief Operating Officer since 2015. In addition, Kristi Jones has been promoted to Chief Operating Officer, and Alan Roemer has been appointed as Chairman of the Board of Directors.

GSK buys out Novartis in $13 billion consumer healthcare shake-up

GlaxoSmithKline (GSK.L) is buying Novartis (NOVN.S) out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches.

PA-18-702: Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp – Clinical Trial Not Allowed)

The purpose of the administrative supplement is to provide support for NIH-funded investigators to participate in an entrepreneurship training course, the Concept to Clinic: Commercializing Innovation (C3i) Program. The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). Through this program, the NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The curriculum and customized mentoring provided by the C3i Program are intended to guide investigators as they assess the commercial viability and potential business opportunity for their innovation. Prospective applicants are strongly encouraged to contact NIH Scientific/Research staff for more information about the program before applying.

Funding Early Stage Companies: Guidance from the Deerfield and NextCure

When: Thursday, April 19, 2018 4:00 – 7:00 PM EST

Where: Johns Hopkins Technology Ventures 1812 Ashland Avenue Baltimore, MD 21205

Deerfield Management is an investment management firm, committed to advancing healthcare through investment, information and philanthropy. Partner and Hopkins alum, Brian Bizoza, MD will talk to their investment strategy and their work advancing early technologies from major academic institutions.

JHU Launches New Concentration in Regenerative and Stem Cell Technologies – News – Johns Hopkins University Montgomery County Campus

Johns Hopkins University is launching a new concentration in Regenerative and Stem Cell Technologies within the Master of Science in Biotechnology. Students will become knowledgeable about areas including regenerative medicine, cell therapy, gene therapy and tissue engineering.

Senseonics Announces Favorable Outcome of FDA Advisory Committee on the Eversense System – Senseonics

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced a favorable outcome of the U.S. Food and Drug Administration (FDA) Clinical Chemistry and Clinical Toxicology Devices meeting on the Eversense system. The panel, comprised of independent medical experts, voted unanimously, 8 to 0, that the benefits outweigh the risks, voted unanimously, 8 to 0, that the system is safe, and voted unanimously, 8 to 0, that the system is effective.

WeWork to Open First Maryland Location on University of Maryland Campus – UMD Right Now

Adding to the growing momentum in Prince George’s County, WeWork, a global leader in coworking with more than 200 locations in 21 countries around the world, has selected College Park for its first location in the State of Maryland. As part of a new partnership model, this will be the first WeWork on a college campus, located in the University of Maryland’s Discovery District.

The South’s Most Active Startup Investors – TEDCO Listed

The American South is not all barbecue and shrimp and grits. It turns out that there are plenty of interesting startup companies in the region, and where there are startups, there are investors too.

Student-run incubator gets startups off the ground – Hub

You’re a student, and you’ve got an idea for a new app. It’s handy. It’s intuitive. It solves some commonplace problem you’ve encountered yourself too many times to count. This idea of yours is going to take off, you know it.

Blockchain, AI and robotics: How future tech will simplify federal procurement

Created in 1974, the Federal Acquisition Regulation provides “uniform policies and procedures for acquisition” to ensure integrity, fairness, and openness in federal procurement. And for over 40 years now, federal agencies have implemented numerous contract writing and support systems. But no one technology has made it dramatically easier for contracting officers or industry.

Mar 27 2018

Love0

297th Edition – March 27, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

March 27, 2018

Montgomery County Council Approves Biotech Grant Program | Montgomery Community Media

The Montgomery County Council on Tuesday unanimously approved Tuesday a county matching fund for businesses that receive federal grants.

Councilmember George Leventhal spearheaded the grant, which was co-sponsored by the eight remaining council members.

New York firm leads $40M Series A for Baltimore-based Dracen Pharmaceuticals – Technical.ly Baltimore

A biotech company founded by Johns Hopkins researchers to develop new drugs to fight cancer said this week that it is raising $40 million in Series A funding.

The round for Dracen Pharmaceuticals was led by Deerfield Management Company, a New York–based firm which invested $36 million in the round.

TEDCO’s Seed Fund invested $1.2 million in these 5 startups – Technical.ly Baltimore

TEDCO announced investments from its seed fund in five startups this week, including three from Baltimore.

Taken together, the latest funding from Maryland’s quasi-public agency backing early-stage companies totals $1.2 million. Here’s the funding breakdown:

The State of the Healthcare Industry and the Impact on Investment Banking/Capital Markets – BHI CEO Rich Bendis to Speak

Wednesday, April 18, 20185:00 PM – 8:00 PM

Please join us on Wednesday, April 18, 2018 for a Healthcare Panel presentation and networking event at the INOVA Personalized Health Conference Center.

Cocktails and hors d’oeuvres will be provided.

Novavax details ‘pre-commercialization activities,’ $1.5B sales target for RSV vaccine | FiercePharma

Novavax may be years away from a potential approval of its RSV vaccine, but on the company’s recent year-end conference call, executives talked up the candidate’s commercial appeal and the steps they’re taking now to prepare for a possible rollout.

Alexandria Real Estate Equities, Inc. Appoints Jennifer J. Banks and Larry J. Diamond as Co-Chief

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, today announced that its board of directors has appointed Jennifer J. Banks and Larry J. Diamond as co-chief operating officers, effective April 23, 2018. Ms. Banks will assume additional responsibilities related to leading the company’s risk management operations and will continue as general counsel and corporate secretary. Mr. Diamond will assume a national role overseeing the company’s real estate property operations and will continue as regional market director of Maryland.

How Martine Rothblatt and James Park Are Using Big Data – Fortune

In some ways Martine Rothblatt, the founder and chairwoman of United Therapeutics, a Maryland-based biotechnology company, and James Park, the CEO and co-founder of consumer fitness company Fitbit, are unusual health care leaders and entrepreneurs. Both came from outside the industry—Rothblatt previously created SiriusXM radio, among other things; meanwhile the inspiration for Park’s popular family of wearable devices was the Nintendo Wii— and neither set out steeped in the regulatory arts of American healthcare.

Maryland Senate approves Amazon HQ2 incentive package – Washington Business Journal

The Maryland state Senate signed off on $5.6 billion in tax incentives to lure Amazon.com Inc. to Montgomery County on Monday night.

Baltimore and BHI Client medical device startup Perceptive Navigation LLC looks to raise $4 million – Baltimore Business Journal

Baltimore medical device firm Perceptive Navigation LLC is looking to raise $4 million in new funding, according to a recent filing with the U.S. Securities and Exchange Commission.

How Baltimore’s Harpoon Medical secured an exit strategy 2 years before its $100M acquisition by Edwards Lifesciences Corp. – Baltimore Business Journal

Investors got big returns on the initial sale and could see millions more over the coming years, as Harpoon’s device continues on the path to U.S. regulatory approval.

American Gene Technologies Gains Additional Immuno-Oncology Patent | American Gene Technologies

American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced receipt of a second immuno-oncology patent on the stimulation of gamma delta T cells for treating solid tumors in epithelial cancers. U.S. Patent No: 9,914,938 dated March 13, 2018 further consolidates AGT’s intellectual property position surrounding its novel gene therapy platform. The patent describes AGT’s unique lentivirus vector approach to modify tumors for potent activation of naturally-occurring T cells in the immune system providing a highly-effective immune response and destruction of tumors.

2018 BioHealth Capital Region Forum: Time to Register

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

2018 BHCR Crab Trap: Last week to apply to win $10,000 and present to world class judges

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

Innovation Village ready to bring startup resources, venture capital together in new Baltimore HQ – Baltimore Business Journal

Eighteen companies ranging in maturity and focus, from software building to bag making, will be housed in the newly renovated HQ by the end of the month.

These two Baltimore biotech hubs are partnering to help scientist-entrepreneurs – Technical.ly Baltimore

A pair of bio-oriented spaces in Baltimore are looking to provide extra help to scientists building companies out of discoveries.

The Inner Harbor–based Institute of Marine and Environmental Technology (IMET) and Baltimore Under Ground Science Space (BUGSS) have a new partnership, according to leaders from both spots.

Johns Hopkins leads all U.S. universities in research spending for 38th year in a row | Hub

Johns Hopkins University led all U.S. universities in research and development expenditures for the 38th consecutive year in fiscal year 2016, spending $2.431 billion on projects like fighting dengue, finding the functional age of cells, and explaining why the universe is making fewer stars.

WellDoc Announces Formation of Scientific Advisory Team

WellDoc®, a leading digital therapeutic company, announces today the formation of its scientific advisory team whose expertise spans cardiology, health behavior, endocrinology, primary care and pharmacy-based diabetes education and care. Richard Katz, MD, Janet Duni, RN, BSN, MPA, CCM, Pablo Mora, MD, Nancy D’Hondt, RPh, CDE, FAADE, Edwin Fisher, PhD and Charlene Quinn, PhD have each been involved in WellDoc’s digital health journey with product enhancement, evaluation, or implementation and have been asked to now formally serve as scientific advisors to the company.

CASI Pharmaceuticals Announces $50 Million Private Placement To Prepare Company For Commercialization In China

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces today a $50 million private placement. The Company has entered into definitive securities purchase agreements pursuant to which the Company will issue 15,432,091 shares of its Common Stock with accompanying warrants to purchase 6,172,832 shares of its Common Stock. The purchase price for each share of Common Stock and warrant is $3.24. The warrants will become exercisable 180 days after issuance at a $3.69 per share exercise price, and will expire five years from the date of issuance. On March 19, 2018, the consolidated closing bid price per share of Common Stock was $3.19.

Akonni Biosystems Announces Strategic Partnership with Major Chinese Diagnostics Company Righton

Akonni Biosystems Inc. and Chinese in vitro diagnostics company, Righton, announce a commercial agreement that enables Righton to sell Akonni’s products for nucleic acid purification and molecular diagnostics to researchers, clinical laboratories, and hospitals in China. The products to be sold include TruTip®, Akonni’s best-in-class sample preparation technology, which is low-cost and simple, yet highly effective at purifying DNA and RNA from the most difficult sample types. In addition, for diagnostic applications, Righton plans to commercialize Akonni’s TruDiagnosis® system based on the proprietary TruArray® multiplexed diagnostic solutions. Righton has made an equity investment of $7.5 million USD in Akonni’s series D fundraising round bringing the total investments in the Series D round to $13.9 million USD.

A whopping 80 percent of all venture capital investment goes to just three states. That has to change. – Recode

Our country faces an ever-growing number of challenges in the 21st century, but all too often our political dialogue can’t even begin to scratch the surface. While Washington remains mired in its usual partisan fights, entire communities across the country — especially in the Midwest — have been locked out of an economy that has moved away from the manufacturing base that helped build the strongest middle class the world has ever seen.

MCCC GovConNet Procurement Conference – Pathway to Growth

Friday, May 18, 2018 7:30AM – 3:00PM

Largest Regional Small Business Procurement Conference

MCCC GovConNet Procurement Conference gives over 800 attendees the unique opportunity to gain valuable insights and meet directly with key purchasing agents from a variety of prime contractors and federal, state, and local government agencies.

Lupin launches generic Lodosyn® tablets in the US

Pharma major Lupin announced the launch of its Carbidopa Tablets 25mg having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin’s Carbidopa Tablets, 25mg is the generic equivalent of Aton Pharma, Inc.’s Lodosyn® Tablets, 25 mg. It is indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism, which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication.

See How Much Your Agency’s Spending Would Increase Under the 2018 Omnibus – Oversight – GovExec.com

The $1.3 trillion fiscal 2018 funding package sent to President Trump early Friday includes big boosts for almost all of the major federal agencies, thanks to a broader two-year budget deal increasing spending caps that President Trump signed last month.

HHS Secretary Azar to Name Robert R. Redfield, M.D., Director of the Centers for Disease Control and Prevention | HHS.gov

On Wednesday, the Department of Health and Human Services announced that Secretary Alex Azar will name Robert R. Redfield, M.D., as the 18th Director of the Centers for Disease Control and Prevention and Administrator of the Agency for Toxic Substances and Disease Registry.

AACR president-elect to focus on health disparities, convergence science

Elizabeth M. Jaffee, MD, will become president of American Association for Cancer Research next month.

Jaffee is deputy director of Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, as well as associate director of Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins.

Maryland, Anne Arundel County Announce Support for Paragon Bioservices’ Expansion

The state of Maryland and the Anne Arundel County Economic Development Corp. (AAEDC) announced today their support of Paragon Bioservices’ new commercial manufacturing facility under development in Anne Arundel County and the addition of 200 new jobs over the next four years. Earlier this year, Paragon, a leading biologics contract development and manufacturing organization (CDMO) with expertise in gene therapy and next-generation vaccines, announced plans to lease 150,000 square feet in the BW Gateway development on Harmans Road.

Jeff Vinik’s latest big investment: $12 million in startup accelerator Dreamit

Tampa Bay Lightning owner and developer Jeff Vinik is investing $12 million in Dreamit, an early-stage venture fund and startup accelerator with offices in New York, Philadelphia and — in the foreseeable future — Tampa.

Here Are All the Ways Sugar Is Actually Killing You

Do you find it nearly impossible to resist the opportunity to devour a cupcake, brownie, or doughnut? You’re not alone. Most of us jump at the chance to satisfy our sweet tooth, even though we know it isn’t good for us. Too many people, however, take an all-or-nothing approach when it comes to junk food, which can make it hard to quit. You don’t have to stop eating sugar completely, but eating less of it could improve and even save your life.

In 1887, Nurses Had To Follow These 9 Ludicrous Rules

If you’ve been to the hospital recently, you’ve probably noticed that the hospital relies on nurses in order to keep everything running smoothly. In fact, according to the United States Bureau of Labor Statistics, there are over 3.1 million nurses in the United States alone.

The Struggle to Build a Massive ‘Biobank’ of Patient Data – The New York Times

This spring, the National Institutes of Health will start recruiting participants for one of the most ambitious medical projects ever envisioned.

Twitter for Scientists: an Idea Whose Time Has Finally Come? – The Chronicle of Higher Education

Tweeting has long posed a dilemma for scientists. There’s abundant evidence that widely sharing a research finding in just one or two simple sentences greatly increases its use and effectiveness.

Scientists launch global effort to find the next diabetes drug – ScienceBlog.com

USC researchers have launched a massive scientific effort to construct a detailed, virtual 3-D model of the pancreatic beta cell and its components — a global project that aims to one day curb the worldwide rise of diabetes.

Mar 20 2018

Love0

296th Edition – March 20, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

March 20, 2018

Montgomery County Economic Development Corporation (MCEDC) CEO of MCEDC, David Petr, Joins Rich Bendis for Latest Episode of the BioTalk Podcast

This discussion covers how David arrived in Maryland, the role of MCEDC in the BioHealth Capital Region, and why Montgomery County is a great place to do business.

Before becoming the inaugural President and CEO of MCEDC, David was with the Central Florida Development Council, where as President and CEO, he achieved record-setting job creation and capital investment results. Previously, David was the Executive Director of the Winter Haven Economic Development Council in Florida. In Texas, he has held key marketing management positions in economic development and was an advertising agency owner in Austin.

Listen now on iTunes , Google Play , and TuneIn.

FDA Breakthrough Device Designation for blood infection test

The FDA’s drive to accelerate access to new medical device technologies continues, with a new product from 3i Diagnostics receiving a Breakthrough Device Designation.

ExeGi Pharma Launches High Potency Veterinary Probiotic To Help Manage GI Tract Illnesses In Dogs

ExeGi Pharma LLC, a company focused on developing and commercializing live biotherapeutics and probiotic treatments, announced today that it has launched Visbiome® Vet, a new high potency probiotic for use in dogs to help support normal inflammatory responses in the gastrointestinal (GI) tract and to help normalize gut health.

2018 BHCR Crab Trap: Only a month left register to win $10,000 and present to world class judges

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

Novavax CEO Stanley Erck calls last quarter ‘the most significant in Novavax corporate history’ – Washington Business Journal

Novavax CEO Stanley Erck said he believes the last quarter was “the most significant in Novavax corporate history.”

The reason? Vaccines, specifically clinical results from the Gaithersburg company’s two lead vaccine programs: RSV for infants via maternal immunization and NanoFlu for seasonal flu.

How to Boost Biotech in Montgomery County – YouTube

Jarrod Borkat of MedImmune says what would help MedImmune would be other large biotech companies located in Montgomery County. Although he expects his company would lose talent, it would be a net gain.

Baltimore medical device startup Perceptive Navigation LLC looks to raise $4 million – Baltimore Business Journal

Baltimore medical device firm Perceptive Navigation LLC is looking to raise $4 million in new funding, according to a recent filing with the U.S. Securities and Exchange Commission.

2018 BioHealth Capital Region Forum: Time to Register

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

UMBC’s president is an activist, innovator and ‘mega nerd.’ His latest role: Giddy basketball fan – The Seattle Times

Freeman Hrabowski III, the university president and most notable dreamer at Maryland Baltimore County, didn’t close his eyes until 6 a.m. Saturday. He had too many text messages to answer, too many calls to take, too many voice mails to retrieve. He had too many people to hug, too many whys and hows to try to explain, too many Friday night thrills to relive.

How Much Can a University Make of a March Madness Cinderella Story? – The Chronicle of Higher Education

At halftime, with players locked in a surprising tie with the top-ranked men’s basketball team in the country, the Twitter feed of the University of Maryland-Baltimore County’s athletic department seized the spotlight to make a sales pitch.

Who is University of Maryland, Baltimore County?

The University of Maryland, Baltimore County woke up on Friday as just another small basketball program looking forward to a run against a No. 1 seed in the NCAA tournament.

Maryland’s ‘internet creators’ added $101.3M to the state’s economy in 2016 – Baltimore Business Journal

Platforms such as Amazon Publishing, Etsy and Instagram have yielded an entire new market of online artists and creators.

Roche buys Flatiron Health for $2.1 billion – Axios

Roche is buying out the rest of Flatiron Health for $1.9 billion, the companies said Thursday. The total investment for Roche, a drug maker based in Switzerland, is about $2.1 billion in cash since it already owned about 13% of Flatiron, a tech company that handles electronic health records and data mining specifically for cancer doctors, researchers and patients.

Lupin launches generic Safyral® tablets in the US

Pharma major Lupin announced the launch of its Tydemy™ Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg and Levomefolate Calcium, 0.451mg) having received an approval from the United States Food and Drug Administration (FDA) earlier.

20K Value Research Prize Could be Yours!

Healthwise and GetWellNetwork Deliver Award-Winning Health Education

Healthwise and GetWellNetwork® announced today they will partner in offering health education to health care providers and their patients. GetWellNetwork will add over 600 Healthwise patient education videos to its current suite of patient experience technologies that deliver Precision Engagement™ across the care continuum.

Baltimore Emerging Technology Center Ranked 7th in UBI’S World Incubator Summit Awards for World of Top Business Incubator – Collaborating with University

ETC (The Emerging Technology Centers), Baltimore City’s technology and innovation center and award-winning entrepreneur support organization, was ranked seventh, globally, in UBI’S World Incubator Summit Awards for World of Top Business Incubator – Collaborating with University.

ETC announces new seven-member, 2018 Accelerate Baltimore cohort – Baltimore Business Journal

Emerging Technology Centers announced the seven companies that have been accepted into its 2018 Accelerate Baltimore cohort.

Scheer Partners represents Supernus Pharmaceuticals, Inc

Scheer Partners, the leading provider of fully integrated commercial real estate services in the Washington and Baltimore metropolitan areas, announced today that it has negotiated on behalf of Supernus Pharmaceuticals, Inc., a 118,000-square-foot headquarters lease at 700 Quince Orchard Road, a building owned by the Rock Creek Fund.

Hopkins Spin-Out Proscia Inks Agreement to Bring Deep Learning Technology to Dermatopathology

Proscia Inc., creators of AI-powered digital pathology software, today announced it has signed a first-of-its-kind agreement with one of the largest dermatopathology labs in the country, signaling Proscia’s entrance into the dermatopathology market and ushering in a new era of digital and computational pathology applied to dermatology.

UMD Researchers Fearlessly Pursue Solutions in Health, Security, Energy, and More – UMD Division of Research

The year 2017 marked yet another exciting period of innovation and growth for the University of Maryland (UMD) research community, with over 170 inventions disclosed and 52 patented, 46 technologies licensed, and the receipt of the largest investment in UMD history in total of $219.5 million from the A. James and Alice B. Clark Foundation. Researchers broke barriers in fields related to agriculture, information management, biotechnology, and energy, making discoveries and inventing technologies that have the potential to make positive impacts on the planet and on people’s lives around the globe.

Johns Hopkins scientists genetically engineer malaria-resistant mosquitoes – Fox News

Mosquitoes are bad news when it comes to the spread of malaria, a deadly disease which kills hundreds of thousands of people each year. We previously covered a range of approaches to cracking down on this problem — ranging from apps which track disease-carrying mosquitoes by listening to their buzz to a plan to release genetically engineered killer mosquitoes to hunt down their disease-carrying wild counterparts.

Kaiser Permanente, Village Capital unveil 10 startups in Health: US 2018 program – MedCity News

Village Capital, a venture capital firm, and Kaiser Permanente have teamed up to address the needs of the aging population in America through a new program called Health: US 2018.

8 women medtech innovators you need to know – Medical Design and Outsourcing

As we celebrate more women becoming medtech leaders and paving the way for innovation, it’s important to remember the many accomplishments women have already made when it comes to the advancement of health and medicine.

Mid Atlantic Bio Angels Initiates Second Investment Pool and Makes Inaugural Investment in POP Medical Solutions, Ltd. | StockGuru SmallCap Alerts on Penny Stocks

Mid Atlantic Bio Angels (MABA) announces today the initiation of a second closed-end investment pool (Pool II) funded by current, active MABA members, and the inaugural investment from that pool made into Israel-based POP Medical Solutions Ltd., which focuses on the treatment of pelvic organ prolapse (POP).

Become a USDA SBIR Success Story! – Webinar

Wed, Apr 11, 2018 2:00 PM – 3:30 PM EDT

USDA ARS and the USDA SBIR program formed a partnership to encourage USDA SBIR applicants to develop research collaborations with ARS scientists and/or to license ARS technologies. The purpose is to increase the likelihood of success by providing both money and technologies to small U.S. businesses. The relevant language in the SBIR’s “Request for Application” states: “Additional factors that will be considered in the review process include whether an application involves a Cooperative Research and Development Agreement (CRADA) with a USDA laboratory, or a license to a USDA technology, or is a resubmission.”

Why the Pharmaceutical Industry is Booming in Japan – SPONSOR CONTENT FROM THE GOVERNMENT OF JAPAN

Older people need more medicine. That rule of life is no secret to pharmaceutical companies across the globe. Many also realize that Japan’s rapidly aging population presents a unique business opportunity. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The Japanese market also is expected to grow annually. The lessons learned there will be critical as the population grows older in many other markets.

New state website is designed to answer entrepreneurs’ start-up questions – Baltimore Sun

The Maryland Department of Assessments and Taxation unveiled a new website Monday designed to help small business owners and entrepreneurs plan, start, manage and grow their businesses.

Mar 13 2018

Love0

295th Edition – March 13, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

March 13, 2018

2018 BHCR Crab Trap: Apply Now!

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

2018 BioHealth Capital Region Forum: Time to Register

April 23-24 | 1 MedImmune Way, Gaithersburg MD 20878

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

SBIR Application Support

Have you drafted your application for the April 5th SBIR Funding application deadline? For qualified companies, BioHealth Innovation, will provide an additional review and support. If interested, email BHI@BIoHealthInnovation.org by this Friday, March 16th.

Supernus Pharmaceuticals shifts headquarters from Rockville to Gaithersburg – Washington Business Journal

After a year of surging growth, Supernus Pharmaceuticals Inc. is building out a new home double its current size.

PointClickCare and Redox to Bridge the Gap Between Acute and Post-Acute Markets with Strategic Partnership | Business Wire

PointClickCare Technologies, the leading cloud-based software vendor for the long-term and post-acute care (LTPAC) market, announced today its strategic partnership with Redox Inc., the leading integration platform for healthcare data exchange. Together, PointClickCare and Redox will work to bridge the gap between the acute and post-acute markets, empowering health systems with the visibility required for a truly coordinated and collaborative approach to care delivery across the healthcare continuum.

Participate in Summer RISE 2018!

Summer R.I.S.E. (Real Interesting Summer Experience) is a unique opportunity for Montgomery County youth to explore potential careers and for our local businesses to participate in developing a talent pipeline. The initiative is led by WorkSource Montgomery, Inc. (WSM), Montgomery County Public Schools (MCPS) and supported by county and state government partners, local businesses and non-profit organizations. Local businesses and governmental organizations volunteer to bring rising high school juniors and seniors into their workplaces to provide hands‐on, real world career experiences.

High Visibility Opportunities for Small Companies at BIO 2018

Will Your Company be the Buzz of BIO?

Are you an innovative biotech company that is R&D-intensive and looking to develop strategic partnerships within the industry? Nominate your company to be the Buzz of BIO!

Winners receive complimentary registration that includes BIO One-on-One Partnering™, a Company Presentation slot in the BIO Business Forum, and marketing promotion to thousands of industry leaders.

Nominations End March 16

CMS Chief Seema Verma Unveils 2 EHR Platforms at HIMSS Annual Conference

The Centers for Medicare and Medicaid Services has announced a new initiative designed to provide patients access to their electronic health records and share their data with their preferred health care providers.

Rexahn Pharmaceuticals Reports Full Year 2017 Financial Results

Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced financial results for the year ended December 31, 2017.

Life science industry impacts N.J. economy in big way, C&W report says – ROI-NJ

Life science industry impacts N.J. economy in big way, C&W report says By Emily Bader New Jersey | Mar 7, 2018 at 11:44 am

The life science industry is fueling New Jersey’s economy through revenue and job growth, according to a report by Cushman & Wakefield.

Vanda Pharmaeuticals says Hetlioz is a big step closer to addressing jet lag disorder – Washington Business Journal

Millions of travelers suffer from jet lag every year. And now Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) said one of its drugs successfully addressed the problem with hundreds of volunteers in a late-stage clinical trial.

Sonavex Submits 510(k) Application to FDA, Dials Up Series A to $4.5M – Sonavex

Sonavex, Inc. announced today the final closure of its expanded $4.5M Series A and filing of a 510(k) submission to the U.S. Food and Drug Administration (FDA) for its EchoMark device. The proceeds will accelerate Sonavex’s commercial launch later this year and support further product development. Participants in the additional financing included Fusion Fund (aka NewGen Capital), FundRx, and existing investors.

TEDCO Accepts ClearMask into mdPACE Program — ClearMask

TEDCO, Maryland’s economic engine for technology companies, inducts ClearMask into its mdPACE program to assist in bringing its life-changing innovation to market. Baltimore-based, ClearMask LLC is the developer of the country’s first, full-face transparent surgical mask designed to help healthcare entities reduce medical errors caused by miscommunication and provide a better experience for deaf patients and other patient groups who heavily rely on visual cues, including children, limited English proficiency patients, and immunosuppressed patients who cannot see the smiles of their loved ones and care team.

Symbiont Health Wins UMD Pitch Dingman Competition, Chaired by Robert Hisaoka – Robert H. Smith School of Business, University of Maryland

Symbiont Health, maker of innovative technology to detect falls for seniors and nursing home patients, took home the $15,000 grand prize at yesterday’s Pitch Dingman Competition, the University of Maryland’s business competition chaired by businessman and philanthropist Robert G. Hisaoka. The competition awarded nearly $30,000 in seed funding to top student entrepreneurs in a “Shark Tank”-style pitch session, hosted by the Dingman Center for Entrepreneurship at the Robert H. Smith School of Business.

23andMe Granted First FDA Authorization for Direct-to-Consumer Genetic Test on Cancer Risk – 23andMe Media Center

23andMe, Inc., the leading personal genetics company, today received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk. The authorization allows 23andMe to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian and prostate cancer.

Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care

The Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR-IMAT) solicitation is a companion SBIR funding opportunity announcement to the NCI Innovative Molecular Analysis Technologies (IMAT) Program aimed at the inception, development, integration, and application of novel and emerging technologies in support of cancer research, treatment, diagnosis, and prevention.

Stem cells could boost this Maryland baby’s heart and chance for a normal life – Baltimore Sun

Surgeons trying a new way to save the life of a baby born with half a heart stood over her open chest and waited for the FedEx box.

Free, open office hours for aspiring and current entrepreneurs

Get answers from experienced entrepreneurs and legal/business professionals on how to build a successful startup company. Receive free and impartial advice, brainstorm business strategies, investigate funding opportunities and learn about the vast resources available to entrepreneurs.

Wednesday, March 14, 2018, 4-6 p.m.

TAP Building, 387 Technology Drive, Room 1105, UMD

The real trade war won’t be fought over metals: Silicon Valley braces for tech battles – News – providencejournal.com – Providence, RI

The dispute is already underway. In August, the Trump administration initiated a sweeping investigation into Chinese trade practices, including whether Chinese firms are investing in U.S. companies to steal their technology and whether they are forcing joint ventures, pressuring American companies that invest in China to transfer technology to a Chinese partner, or hacking U.S. companies’ software.

Amazon tours D.C., Maryland and Virginia in search for new headquarters – The Washington Post

Officials from Amazon.com toured sites in Washington, Montgomery County, Md., and Northern Virginia last week — the latest sign that the tech giant is seriously considering adding a second headquarters with as many as 50,000 jobs to the D.C. area, according to officials in all three jurisdictions.

Virginia Tech Wins Fourth Annual Deloitte Foundation Cyber Threat Competition

A team of students from Virginia Tech claimed victory at the fourth annual Deloitte Foundation Cyber Threat Competition for their analysis and incident response approach to a simulated cyber event. Anirudh Bagde, Danny Colmenares, Nicholas Herman and Andy Wong, the school’s team members, each received $2,000 in scholarship money.

Epigenetics therapy shows promise in patients with lymphoma – ScienceDaily

New compounds targeting epigenetics have shown remarkable early activity in patients with lymphoma, according to data presented at the TAT (Targeted Anticancer Therapies) International Congress 2018 in Paris, France. ESMO’s phase-I oncology meeting featured early clinical studies with BET inhibitors and EZH2 inhibitors.

Life Sciences Cloud and Infrastructure Conference (4/5)

Join ISPE Chesapeake Bay Area Chapter, Maryland Tech Council, BioHealth Innovation and ByteGrid for a one day Life Sciences Cloud & Infrastructure Conference.

Listen to speakers, including Krishna Ghosh, Ph. D., Senior Policy Advisor at the Food and Drug Administration, and the co-chairs of the GAMP Cloud Special Interest Group and get a behind-the-scenes data center tour of ByteGrid’s flagship Silver Spring facility.

You’ll also get valuable insights into cloud adoption in the regulated Life Sciences industry, hear about updates to the revised ISPE GAMP Good Practice Guide on IT Infrastructure and much more!

The agenda and speakers are listed here: https://hubs.ly/H0b3TKs0

March 14th – BioBuzz with JHU MoCo – Rockville

Join BioBuzz and founding sponsor The Johns Hopkins University Montgomery County Campus at Bar Louie on March 14th. The Johns Hopkins University Montgomery County Campus offers part-time graduate courses in biotechnology fields. Students attend classes in the evenings and on Saturdays, enabling them to hold full-time jobs during the day. Depending on the degree area, students can fully complete their coursework in Montgomery County. Other students take some courses in Baltimore and/ or online.

Mar 06 2018

Love0

294th Edition – March 6, 2018

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

March 6, 2018

New Biotech in Gaithersburg Bringing 100 Jobs | Montgomery Community Media

A new biotech company is opening in Gaithersburg, and is bringing with it 100 new jobs in the next three to five years.

AstraZeneca spinout bags $250M, pipeline headed by late-phase autoimmune drug – FierceBiotech

AstraZeneca has carved off six inflammation and autoimmune assets to create a new biotech, Viela Bio. The startup put together a $250 million series A round and a management team from its parent company to guide the mix of clinical and preclinical programs forward.

Win $10,000 at the 2018 BHCR Crab Trap

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018

Finalists will be announced: April 9th, 2018

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

Attn: Montgomery County BioHealth Companies

Did you know you are required to file for and receive a Hazardous Use Permit every year if you are storing, handling or using any hazardous substance in excess of 5 gallons or 50 pounds? (Failure to do so could result in civil and criminal penalties.) Learn how to do this at the free training session, March 8th, at the Germantown Innovation Center, hosted by BioHealth Innovation and Montgomery County’s Office of Emergency Management and Homeland Security

Bring your laptop and materials inventory to a 15 minute 1:1 meetings with County staff and they will help you register your materials as required on the County’s website. (Pre-registration for these appointments is REQUIRED).

To schedule an appointment, send your top 3 time preferences to BHI@BioHealthInnovation.org

Meeting slots are assigned on a first-come, first-served basis: 8:45, 9:00, 9:15 a.m. – Open 9:30-11:30 a.m. – Booked 11:30, 11:45 a.m. – Open 12:00, 12:15 p.m. – Open

More information: https://Hazmat.MontgomeryCountyMD.gov

Baltimore medical device firm Sisu Global Health launching first product, raising money for growth – Baltimore Business Journal

Baltimore’s Sisu Global Health Inc. is launching its first medical device product and planning for growth in 2018.

Sisu, founded in 2014, specializes in creating health technologies to solve public health problems. The company is backed by $2.1 million in funding from various sources including local investors Camden Partners, the Abell Foundation and state-backed Maryland Technology Development Corp. It also won an investment from venture capitalist and AOL co-founder Steve Case, through his Rise of the Rest initiative.

Emergent BioSolutions gets $26M contract for medical treatment – Maryland Daily Record

The Centers for Disease Control and Prevention has awarded Emergent BioSolutions Inc. a $26 million contract to continue to supply a medical treatment to the government.

Maryland Tech Council Announces the Innovation for Impact Prize and the Finalists for the 30th Anniversary Industry Awards Celebration | Business Wire

The Maryland Tech Council (MTC) has announced the finalists for its 30th Anniversary Industry Awards Celebration. Winners will be revealed at a celebration on May 17, 2018 at The Hotel at The University of Maryland. The event, which draws more than 600 executives from the technology and life science communities, celebrates individuals and companies that have made a significant impact in their sectors.

Innovation for Impact Prize – SoBran, Inc.

Tell us about the impact your research may make on the world. You could win a free pre-clinical research study valued up to $20,000 and $1,000 in cash, or additional cash prizes.

SoBran and the Maryland Tech Council are celebrating the transformational science coming out of the Maryland and surrounding area by establishing the Innovation for Impact Prize.

Partnering with Industry for Better Education in Drug Discovery – News – Johns Hopkins University Montgomery County Campus

Natalia Majewska spent the summer after her junior year at Northwestern University interning in a lab at MedImmune, the Gaithersburg, Maryland-based global biologics research and development arm of pharmaceutical giant AstraZeneca. There, she worked in a lab developing synthetic proteins.

This incubator is helping Johns Hopkins undergrads become entrepreneurs – Technical.ly Baltimore

A new incubator is helping its first companies at Johns Hopkins this school year. Run by a group of undergraduate students, The Hatchery Incubator is helping undergraduate students who are starting companies.

It’s an initiative of TCO Labs, a nonprofit organization founded by students that’s looking to provide more startup resources on campus.

D.C.-based Lavrock Ventures courts cybersecurity startups with $25 million fund – VentureBeat

Silicon Valley is home to an abundance of VC firms, all of them competing to get in on the next big deal. But VCs also exist (and succeed) outside of the Bay Area. While Washington, D.C. may not be an obvious location to establish a venture capital firm, Lavrock Ventures set its sights on the political capital. The firm announced today that it has closed its first fund at $25 million to invest in early-stage startups at the intersection of enterprise software, cybersecurity, and national security.

PGDx signs licensing deal with Memorial Sloan Kettering Cancer Center – Technical.ly Baltimore

Personal Genome Diagnostics is adding to its IP portfolio to further develop new kinds of cancer tests.

A licensing deal announced Wednesday gives the Canton-based company exclusive rights to develop and commercialize products based on a key discovery at Memorial Sloan Kettering Cancer Center in New York. Financial terms were not disclosed.

A Women’s Leadership Panel Discussion & Dinner

When: Tuesday, March 27, 2018 from 4:00 PM to 7:30 PM EDT

Where: Montgomery College Pinkney Innovation Complex: Science & Technology 20200 Observation Drive Germantown, MD 20876

Join us for our first Women in Pharma event! This community is for those in the pharmaceutical/biotech industry and is a community of mentors, resources across all levels, and provide educational sessions that will be an enabler for career success and work-life balance. All are welcome.

Return on Investment (ROI) Initiative – NIST

The National Institute of Standards and Technology (NIST) is undertaking an ambitious plan to assess Federal technology transfer efforts to enable greater “Return on Investment” (ROI) from the Federal Government’s $140 Billion annual investment in research and development (R&D). NIST is uniquely positioned to implement this initiative through our government-wide leadership role within the Department of Commerce, including delegated (link is external) regulatory authority and responsibility for annual reporting to the President and Congress.

Useful Stats: Employment in “Eds and Meds” by state | SSTI

For decades, state and local economies have leaned heavily on their anchor institutions during times of economic uncertainty and transition. An analysis finds that total employment in “Eds and Meds” industries increased in every state from 2005 to 2015. This article breaks down the growth and geography of Eds and Meds employment at the state level, while next week’s issue of the Digest will explore this data by metropolitan area.

Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate Against Zika Virus NYSE:EBS

Emergent BioSolutions Inc. (NYSE:EBS) and Valneva SE (Euronext Paris:VLA) today announced the initiation of a Phase 1 clinical trial in the U.S. to evaluate the safety and immunogenicity of VLA1601, their vaccine candidate against Zika virus.

JPMorgan wants to become the Amazon of Wall Street – Business Insider

“The first opportunity we have to delight or to upset a client is when they walk through the door either physically or virtually.”

Sounds like a tech executive, right? Jeff Bezos even? The Amazon boss often talks about delighting customers, after all, although until recently the ecommerce giant didn’t really have doors to physically walk through.

Synthetic biology startup Senti Biosciences raises $53 million – Business Insider

Senti Biosciences, a startup that’s looking to make a new treatment that’s upending how we treat cancer, just raised $53 million.

Apple launching medical clinics for employees, the latest move in tech’s healthcare innovation fight – GeekWire

Apple is launching medical clinics for its employees in the latest attempt by a large tech company to address the U.S.’s growing healthcare problem. The new project, called AC Wellness, is launching sometime in the spring, according to its new website.

New technology may protect troops from blast-induced brain injury | EurekAlert! Science News

Researchers from theUniversity of Maryland School of Medicine (UMSOM) and the University of Maryland A. James Clark School of Engineering have developed a new military vehicle shock absorbing device that may protect troops from traumatic brain injury (TBI) after a land mine blast. Over the past 18 years of conflicts in Iraq and Afghanistan, more than 250,000 troops have suffered such injuries.

BioBuzz with JHU MoCo

When: Wednesday, March 14, 2018 from 5:00 PM to 7:00 PM

Where: Bar Louie 150 Gibbs St Rockville, MD 20850

757 LAUNCH celebrates three new resources in support of Hampton Roads entrepreneurship – pilotonline.com

Entrepreneurship is on the rise in Hampton Roads and there’s an event to celebrate it.

757 LAUNCH, from 12:30 p.m. to 2 p.m. on March 30 at the Selden Market in Norfolk, will showcase three new resources to support area entrepreneurs and startups.

HIMSS acquires business accelerator Healthbox – Modern Healthcare

The Healthcare Information and Management Systems Society has acquired Healthbox, looking to tap the business accelerator for its consulting and fund management capabilities.

Big pharma, big data: why drugmakers want your health records

Studying such real-world evidence offers manufacturers a powerful tool to prove the value of their drugs – something Roche (ROG.S) aims to leverage, for example, with last month’s $2 billion purchase of Flatiron Health.

Microsite i.Invest National Youth Entrepreneur Business Competition 2018

The i.Invest Competition is designed to help entrepreneurial-minded youth, ages 13 -19, further advance their business development and pitching skills and connect with mentors, judges and investors from across the country. The competition will:

Showcase the entrepreneurial spirit of the nation’s brightest young leaders;
Provide a venue for entrepreneurs to test their business plan and pitching capabilities;
Offer opportunities for entrepreneurs to earn seed funding and connect with investors and potential customers;
Position entrepreneurs to collaborate with mentors and coaches on the development of viable business models; and
Provide opportunities for entrepreneurs to win cash and in-kind prizes.

How Precision Medicine Will Transform the Pharmaceutical and Healthcare Industries

Across the globe, a collection of healthcare professionals gather around their computer screens in their respective offices in Beijing, Brussels, London, and Los Angeles. A skilled U.S.-based oncologist leads this virtual board in discussing a 38-year-old British patient with advanced lung cancer. Using virtual reality technology, the team is able to simultaneously review the patient’s entire disease profile, including her medical history and lifestyle, and see high-resolution pathology images and all sorts of other biological data.

University of Maryland SGA wants Amazon’s new headquarters to be in Montgomery County – The Diamondback

The University of Maryland’s SGA will send a letter to Amazon supporting Montgomery County for the company’s second headquarters, called HQ2.

BHI Weekly Newsletter Archives

About BioHealth Innovation

Contact

Connect

BHI Weekly Newsletter Archives

About BioHealth Innovation

Contact

Connect

Search